StemCell Institute Inc. (TYO:7096)
1,070.00
+14.00 (1.33%)
Jun 16, 2025, 3:30 PM JST
StemCell Institute Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
Cash & Equivalents | 3,200 | 2,845 | 3,324 | 3,511 | 2,743 | Upgrade
|
Cash & Short-Term Investments | 3,200 | 2,845 | 3,324 | 3,511 | 2,743 | Upgrade
|
Cash Growth | 12.48% | -14.41% | -5.33% | 28.00% | -9.29% | Upgrade
|
Accounts Receivable | 1,836 | 1,584 | 1,137 | 593 | 280 | Upgrade
|
Other Receivables | - | - | - | - | 64 | Upgrade
|
Receivables | 1,836 | 1,584 | 1,137 | 593 | 344 | Upgrade
|
Inventory | 50 | 42 | 39 | 40 | 32 | Upgrade
|
Prepaid Expenses | 48 | 39 | 43 | 32 | 29 | Upgrade
|
Other Current Assets | 38 | 5 | 2 | 2 | 2 | Upgrade
|
Total Current Assets | 5,172 | 4,515 | 4,545 | 4,178 | 3,150 | Upgrade
|
Property, Plant & Equipment | 1,155 | 665 | 648 | 647 | 576 | Upgrade
|
Long-Term Investments | 843 | 1,178 | 411 | 203 | 195 | Upgrade
|
Other Intangible Assets | 132 | 41 | 24 | 24 | 15 | Upgrade
|
Long-Term Deferred Tax Assets | 60 | 5 | 44 | 28 | 20 | Upgrade
|
Other Long-Term Assets | 1 | 1 | 1 | 2 | 2 | Upgrade
|
Total Assets | 7,500 | 6,543 | 5,811 | 5,215 | 3,958 | Upgrade
|
Accounts Payable | 25 | 36 | 30 | 29 | 21 | Upgrade
|
Accrued Expenses | 86 | 70 | 65 | 59 | 57 | Upgrade
|
Current Portion of Long-Term Debt | 62 | - | - | - | - | Upgrade
|
Current Portion of Leases | 4 | 2 | 1 | - | - | Upgrade
|
Current Income Taxes Payable | 334 | 179 | 192 | 153 | 105 | Upgrade
|
Other Current Liabilities | 3,807 | 3,473 | 3,143 | 2,810 | 2,405 | Upgrade
|
Total Current Liabilities | 4,318 | 3,760 | 3,431 | 3,051 | 2,588 | Upgrade
|
Long-Term Debt | 437 | - | - | - | - | Upgrade
|
Long-Term Leases | 14 | 6 | 4 | - | - | Upgrade
|
Other Long-Term Liabilities | 64 | 59 | 57 | 53 | 43 | Upgrade
|
Total Liabilities | 4,872 | 3,852 | 3,513 | 3,112 | 2,636 | Upgrade
|
Common Stock | 704 | 704 | 704 | 704 | 374 | Upgrade
|
Additional Paid-In Capital | 589 | 589 | 589 | 589 | 259 | Upgrade
|
Retained Earnings | 1,448 | 1,318 | 1,007 | 809 | 687 | Upgrade
|
Treasury Stock | -94 | - | - | - | - | Upgrade
|
Comprehensive Income & Other | -19 | 80 | -2 | 1 | 2 | Upgrade
|
Shareholders' Equity | 2,628 | 2,691 | 2,298 | 2,103 | 1,322 | Upgrade
|
Total Liabilities & Equity | 7,500 | 6,543 | 5,811 | 5,215 | 3,958 | Upgrade
|
Total Debt | 517 | 8 | 5 | - | - | Upgrade
|
Net Cash (Debt) | 2,683 | 2,837 | 3,319 | 3,511 | 2,743 | Upgrade
|
Net Cash Growth | -5.43% | -14.52% | -5.47% | 28.00% | -9.29% | Upgrade
|
Net Cash Per Share | 261.97 | 276.87 | 323.91 | 693.28 | 563.58 | Upgrade
|
Filing Date Shares Outstanding | 10.23 | 10.25 | 25.62 | 5.12 | 4.87 | Upgrade
|
Total Common Shares Outstanding | 10.23 | 10.25 | 25.62 | 5.12 | 4.87 | Upgrade
|
Working Capital | 854 | 755 | 1,114 | 1,127 | 562 | Upgrade
|
Book Value Per Share | 256.98 | 262.62 | 89.71 | 410.56 | 271.62 | Upgrade
|
Tangible Book Value | 2,496 | 2,650 | 2,274 | 2,079 | 1,307 | Upgrade
|
Tangible Book Value Per Share | 244.07 | 258.62 | 88.77 | 405.88 | 268.54 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.